NAD+ homeostasis in health and disease
Why its notable: human trials show that CJC-1295 raises growth hormone (GH) and insulin-like growth factor (IGF-1) levels in controlled settings, when used with appropriate supervision
Because BPC-157 remains investigational, dosing is not standardized the way FDA-approved medications are
Standard reconstitution for AOD-9604 AOD-9604 typically arrives as lyophilized (freeze-dried) powder in sealed vials, most commonly in 2mg or 5mg quantities
Certain growth hormone secretagogues, such as tesamorelin and epomorlin, can create a strong growth hormone response, leading to high levels of insulin-like growth factor 1 (IGF-1) 5m30s
No universal dose: appropriate use depends on an individuals health profile and is determined by a licensed provider, not a standard number from the internet